Angelika M Vollmar

Title: Angelika M Vollmar: Innovator in Chronic Inflammatory Treatment

Introduction

Angelika M Vollmar is a distinguished inventor based in München, Germany. She has made significant contributions to the field of medicine, particularly in the treatment of chronic inflammatory and fibrotic processes. Her innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Angelika holds a patent titled "Use of Phyllanthus for treating chronic inflammatory and fibrotic processes." This invention relates to the use of Phyllanthus for preventing or treating connective tissue proliferations. It also focuses on maintaining the level of reduced glutathione, inhibiting lipopolysaccharide (LPS)-induced nitric oxide synthase (NOS), and inhibiting the expression of the cyclooxygenase (COX-2) protein. This patent showcases her commitment to advancing medical treatments.

Career Highlights

Angelika is associated with Phytrix AG, where she continues to work on innovative solutions in the medical field. Her expertise and dedication have positioned her as a key figure in her organization, contributing to the development of effective treatments.

Collaborations

Throughout her career, Angelika has collaborated with notable professionals, including Rolf Gebhardt and Michael Manns. These partnerships have enhanced her research and development efforts, leading to impactful innovations.

Conclusion

Angelika M Vollmar is a remarkable inventor whose work in treating chronic inflammatory conditions has the potential to improve countless lives. Her dedication to innovation and collaboration in the medical field is commendable.